Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Nonpeptide GnRH antagonists prepared at Merck & Co.

Feb. 13, 1998

Antipsychotic drugs in development at Janssen

Feb. 13, 1998

DuPont Merck claims new CRF antagonists

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Zeneca's new antibacterial agents active against resistant pathogens

Feb. 12, 1998

Novel approach to HIV therapy described by ML Laboratories

Feb. 12, 1998

Celltech reports crosslinked antibodies for cancer indications

Feb. 12, 1998

Potential new antimigraine agents in development at Allelix

Feb. 12, 1998

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...